| Application no. and date | 11723919.4 (espacenet) (Federated) (European Patent Register), 20110527 | | Patent/reg. no. and date | DK/EP 2575865, 20141217 | | Publication date | 20130410 | | Priority no. and date | EP 10164368, 20100528 | | EP pub. no. and date |
EP 2575865 20130410 | | Effective date | | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50
65929 Frankfurt am Main, DE | | Applicant ref. no. | DE2010/107-EP-EPT | | Inventor | HAUCK, Gerrit, Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
BECKER, Reinhard, Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61P 3/10 (2006.01) , A61P 5/50 (2006.01) | | Title | Farmaceutisk præparat, der omfatter AVE0010 og insulin glargin | | Int. application no. | EP2011058764 | | Int. publication no. | WO2011147980 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
